FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2794685720> ?p ?o ?g. }

• W2794685720 abstract "ABSTRACT Recent data obtained with the live-attenuated tetravalent dengue CYD-TDV vaccine showed higher protective efficacy against dengue virus type 4 (DENV-4) than against DENV-2. In contrast, results from previous studies in nonhuman primates predicted comparable high levels of protection against each serotype. Maximum viral loads achieved in macaques by subcutaneous inoculation of DENV are generally much lower than those observed in naturally dengue virus-infected humans. This may contribute to an overestimation of vaccine efficacy. Using more-stringent DENV infection conditions consisting of the intravenous inoculation of 10 7 50% cell culture infectious doses (CCID 50 ) in CYD-TDV-vaccinated macaques, complete protection (i.e., undetectable viral RNA) was achieved in all 6 monkeys challenged with DENV-4 and in 6/18 of those challenged with DENV-2, including transiently positive animals. All other infected macaques (12/18) developed sustained DENV-2 RNAemia (defined as detection of viral RNA in serum samples) although 1 to 3 log 10 units below the levels achieved in control animals. Similar results were obtained with macaques immunized with either CYD-TDV or monovalent (MV) CYD-2. This suggests that partial protection against DENV-2 was mediated mainly by CYD-2 and not by the other CYDs. Postchallenge induction of strong anamnestic responses, suggesting efficient vaccine priming, likely contributed to the reduction of DENV-2 RNAemia. Finally, an inverse correlation between DENV RNA titers postchallenge and vaccine-induced homotypic neutralizing antibody titers prechallenge was found, emphasizing the key role of these antibodies in controlling DENV infection. Collectively, these data show better agreement with reported data on CYD-TDV clinical vaccine efficacy against DENV-2 and DENV-4. Despite inherent limitations of the nonhuman primate model, these results reinforce its value in assessing the efficacy of dengue vaccines. IMPORTANCE The nonhuman primate (NHP) model is the most widely recognized tool for assessing the protective activity of dengue vaccine candidates, based on the prevention of postinfection DENV viremia. However, its use has been questioned after the recent CYD vaccine phase III trials, in which moderate protective efficacy against DENV-2 was reported, despite full protection against DENV-2 viremia previously being demonstrated in CYD-vaccinated monkeys. Using a reverse translational approach, we show here that the NHP model can be improved to achieve DENV-2 protection levels that show better agreement with clinical efficacy. With this new model, we demonstrate that the injection of the CYD-2 component of the vaccine, in either a monovalent or a tetravalent formulation, is able to reduce DENV-2 viremia in all immunized animals, and we provide clear statistical evidence that DENV-2-neutralizing antibodies are able to reduce viremia in a dose-dependent manner." @default.
• W2794685720 created "2018-04-06" @default.
• W2794685720 creator A5012672486 @default.
• W2794685720 creator A5023217138 @default.
• W2794685720 creator A5026718262 @default.
• W2794685720 creator A5044257209 @default.
• W2794685720 creator A5045006118 @default.
• W2794685720 creator A5080392502 @default.
• W2794685720 creator A5088135368 @default.
• W2794685720 date "2018-06-15" @default.
• W2794685720 modified "2023-10-13" @default.
• W2794685720 title "Improvement of the Dengue Virus (DENV) Nonhuman Primate Model via a Reverse Translational Approach Based on Dengue Vaccine Clinical Efficacy Data against DENV-2 and -4" @default.
• W2794685720 cites W1017348960 @default.
• W2794685720 cites W1031737100 @default.
• W2794685720 cites W1546432997 @default.
• W2794685720 cites W1822185265 @default.
• W2794685720 cites W1931705429 @default.
• W2794685720 cites W1945701139 @default.
• W2794685720 cites W1966396614 @default.
• W2794685720 cites W1968727501 @default.
• W2794685720 cites W1970136118 @default.
• W2794685720 cites W1971363578 @default.
• W2794685720 cites W1974880874 @default.
• W2794685720 cites W1980444528 @default.
• W2794685720 cites W1981895261 @default.
• W2794685720 cites W1996883424 @default.
• W2794685720 cites W2006146542 @default.
• W2794685720 cites W2007109401 @default.
• W2794685720 cites W2033593284 @default.
• W2794685720 cites W2039283951 @default.
• W2794685720 cites W2042603310 @default.
• W2794685720 cites W2044339036 @default.
• W2794685720 cites W2049972031 @default.
• W2794685720 cites W2061831021 @default.
• W2794685720 cites W2065599363 @default.
• W2794685720 cites W2072041855 @default.
• W2794685720 cites W2072764395 @default.
• W2794685720 cites W2076091075 @default.
• W2794685720 cites W2078128788 @default.
• W2794685720 cites W2078595526 @default.
• W2794685720 cites W2081529090 @default.
• W2794685720 cites W2083709201 @default.
• W2794685720 cites W2093692573 @default.
• W2794685720 cites W2094268281 @default.
• W2794685720 cites W2094475393 @default.
• W2794685720 cites W2095851972 @default.
• W2794685720 cites W2097288560 @default.
• W2794685720 cites W2099860386 @default.
• W2794685720 cites W2104989660 @default.
• W2794685720 cites W2113583073 @default.
• W2794685720 cites W2116437087 @default.
• W2794685720 cites W2116471574 @default.
• W2794685720 cites W2117175288 @default.
• W2794685720 cites W2134850550 @default.
• W2794685720 cites W2140139336 @default.
• W2794685720 cites W2140864706 @default.
• W2794685720 cites W2155480356 @default.
• W2794685720 cites W2155660565 @default.
• W2794685720 cites W2161824746 @default.
• W2794685720 cites W2161981238 @default.
• W2794685720 cites W2164079841 @default.
• W2794685720 cites W2170806251 @default.
• W2794685720 cites W2172273799 @default.
• W2794685720 cites W2222158372 @default.
• W2794685720 cites W2319846508 @default.
• W2794685720 cites W2333294867 @default.
• W2794685720 cites W2345297459 @default.
• W2794685720 cites W2411413760 @default.
• W2794685720 cites W2504596968 @default.
• W2794685720 cites W2559855203 @default.
• W2794685720 cites W2785461794 @default.
• W2794685720 doi "https://doi.org/10.1128/jvi.00440-18" @default.
• W2794685720 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/5974474" @default.
• W2794685720 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/29593041" @default.
• W2794685720 hasPublicationYear "2018" @default.
• W2794685720 type Work @default.
• W2794685720 sameAs 2794685720 @default.
• W2794685720 citedByCount "15" @default.
• W2794685720 countsByYear W27946857202018 @default.
• W2794685720 countsByYear W27946857202019 @default.
• W2794685720 countsByYear W27946857202020 @default.
• W2794685720 countsByYear W27946857202021 @default.
• W2794685720 countsByYear W27946857202022 @default.
• W2794685720 countsByYear W27946857202023 @default.
• W2794685720 crossrefType "journal-article" @default.
• W2794685720 hasAuthorship W2794685720A5012672486 @default.
• W2794685720 hasAuthorship W2794685720A5023217138 @default.
• W2794685720 hasAuthorship W2794685720A5026718262 @default.
• W2794685720 hasAuthorship W2794685720A5044257209 @default.
• W2794685720 hasAuthorship W2794685720A5045006118 @default.
• W2794685720 hasAuthorship W2794685720A5080392502 @default.
• W2794685720 hasAuthorship W2794685720A5088135368 @default.
• W2794685720 hasBestOaLocation W27946857201 @default.
• W2794685720 hasConcept C142462285 @default.
• W2794685720 hasConcept C159047783 @default.
• W2794685720 hasConcept C159654299 @default.
• W2794685720 hasConcept C203014093 @default.
• W2794685720 hasConcept C2522874641 @default.
• W2794685720 hasConcept C2779261636 @default.
• W2794685720 hasConcept C2779308166 @default.

• next